|
1
|
Giacalone M, Mastrangelo G and Parri N:
Point-of-care ultrasound diagnosis of retinoblastoma in the
emergency department. Pediatr Emerg Care. 34:599–601. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stathopoulos C, Moulin A, Gaillard MC,
Beck-Popovic M, Puccinelli F and Munier FL: Conservative treatment
of diffuse infiltrating retinoblastoma: Optical coherence
tomography-assisted diagnosis and follow-up in three consecutive
cases. Br J Ophthalmol. Jul 26–2018.(Epub ahead of print). doi:
10.1136/bjophthalmol-2018-312546. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Al-Nawaiseh I, Ghanem AQ and Yousef YA:
Familial retinoblastoma: Raised awareness improves early diagnosis
and outcome. J Ophthalmol. 2017:50539612017.PubMed/NCBI
|
|
4
|
Jenkinson H: Retinoblastoma: Diagnosis and
management-the UK perspective. Arch Dis Child. 100:1070–1075. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fabian ID, Puccinelli F, Gaillard MC,
Beck-Popovic M and Munier FL: Diagnosis and management of secondary
epipapillary retinoblastoma. Br J Ophthalmol. 101:1412–1418. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dehainault C, Golmard L, Millot GA,
Charpin A, Laugé A, Tarabeux J, Aerts I, Cassoux N, Stoppa-Lyonnet
D, Gauthier-Villars M and Houdayer C: Mosaicism and prenatal
diagnosis options: Insights from retinoblastoma. Eur J Hum Genet.
25:381–383. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Parrilla-Vallejo M, Perea-Pérez R,
Relimpio-López I, Montero-de-Espinosa I, Rodríguez-de-la-Rúa E,
Terrón-León JA, Díaz-Granda MJ, Coca-Gutiérrez L and Ponte-Zuñiga
B: Retinoblastoma: The importance of early diagnosis. Arch Soc Esp
Oftalmol. 93:423–430. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ramírez-Ortiz MA, Lansingh VC, Eckert KA,
Haik BG, Phillips BX, Bosch-Canto V, González-Pérez G,
Villavicencio-Torres A and Etulain-González A: Systematic review of
the current status of programs and general knowledge of diagnosis
and management of retinoblastoma. Bol Med Hosp Infant Mex.
74:41–54. 2017.PubMed/NCBI
|
|
9
|
Shah PK, Sripriya S, Narendran V and
Pandian AJ: Prenatal genetic diagnosis of retinoblastoma and report
of RB1 gene mutation from India. Ophthalmic Genet. 37:430–433.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu L, Chen Z and Xing Y: miR-506-3p
inhibits cell proliferation, induces cell cycle arrest and
apoptosis in retinoblastoma by directly targeting NEK6. Cell Biol
Int. Aug 6–2018.(Epub ahead of print). doi: 10.1002/cbin.11041.
View Article : Google Scholar
|
|
11
|
Clarke JI, Forootan SS, Lea JD, Howell LS,
Rodriguez JM, Kipar A, Goldring CE, Park BK, Copple IM and Antoine
DJ: Circulating levels of miR-122 increase post-mortem,
particularly following lethal dosing with pentobarbital sodium:
Implications for pre-clinical liver injury studies. Toxicol Res
(Camb). 6:406–411. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu HL, Nie ZQ, Lu Y, Yang X, Song C, Chen
H, Zhu S, Chen BB, Huang J, Geng S and Zhao S: Circulating miR-125b
but not miR-125a correlates with acute exacerbations of chronic
obstructive pulmonary disease and the expressions of inflammatory
cytokines. Medicine (Baltimore). 96:e90592017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Copier CU, León L, Fernández M, Contador D
and Calligaris SD: Circulating miR-19b and miR-181b are potential
biomarkers for diabetic cardiomyopathy. Sci Rep. 7:135142017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
D'Agostino M, Martino F, Sileno S, Barillà
F, Beji S, Marchetti L, Gangi FM, Persico L, Picozza M, Montali A,
et al: Circulating miR-200c is up-regulated in paediatric patients
with familial hypercholesterolaemia and correlates with miR-33a/b
levels: Implication of a ZEB1-dependent mechanism. Clin Sci (Lond).
131:2397–2408. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bilegsaikhan E, Liu HN, Shen XZ and Liu
TT: Circulating miR-338-5p is a potential diagnostic biomarker in
colorectal cancer. J Dig Dis. 19:404–410. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xing Z, Yu L, Li X and Su X: Anticancer
bioactive peptide-3 inhibits human gastric cancer growth by
targeting miR-338-5p. Cell Biosci. 6:532016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Long J, Luo J and Yin X: miR-338-5p
promotes the growth and metastasis of malignant melanoma cells via
targeting CD82. Biomed Pharmacother. 102:1195–1202. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Huang Y, Qi Z, Sun T and Zhou Y:
miR-338-5p promotes glioma cell invasion by regulating TSHZ3 and
MMP2. Cell Mol Neurobiol. 38:669–677. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shields CL, Mashayekhi A, Au AK, Czyz C,
Leahey A, Meadows AT and Shields JA: The International
Classification of Retinoblastoma predicts chemoreduction success.
Ophthalmology. 113:2276–2280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gutierrez-Camino A, Martin-Guerrero I,
Dolzan V, Jazbec J, Carbone-Bañeres A, Garcia de Andoin N, Sastre
A, Astigarraga I, Navajas A and Garcia-Orad A: Involvement of SNPs
in miR-3117 and miR-3689d2 in childhood acute lymphoblastic
leukemia risk. Oncotarget. 9:22907–22914. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu T, Lin Y and Xie Z: MicroRNA-1247
inhibits cell proliferation by directly targeting ZNF346 in
childhood neuroblastoma. Biol Res. 51:132018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zakrzewska M, Fendler W, Zakrzewski K,
Sikorska B, Grajkowska W, Dembowska-Bagińska B, Filipek I,
Stefańczyk Ł and Liberski PP: Altered MicroRNA expression is
associated with tumor grade, molecular background and outcome in
childhood infratentorial ependymoma. PLoS One. 11:e01584642016.
View Article : Google Scholar : PubMed/NCBI
|
